David G. Standaert

David Standaert practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

David Standaert's NPI, 1588654495, was assigned on October 24, 2005. David Standaert graduated from Washington University School of Medicine in 1988. David Standaert holds Alabama license 27659.

David Standaert's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

David Standaert's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. David Standaert is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where David Standaert practices. Vendor and product names are available with a free account.

Neurology is David Standaert's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. David Standaert is licensed in Alabama.

CMS data shows 256 Medicare services from David Standaert across 5 procedure codes in 2024, for 144 Medicare patients. Medicare paid $11,462 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw David Standaert in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts David Standaert's median patient age at 72, with 41% women.

In 2024, David Standaert wrote 200 Medicare Part D claims for 55 patients. 81% of them were for generic drugs. CMS names the drug for 139 of them, across 6 drugs with 11 or more claims each, at $113,484 in total drug cost. In 2023, CMS named 230 claims across 9 drugs.

David Standaert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists David Standaert as offering telehealth.

Dmand AI links 136 papers to David Standaert, published from 2010 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Parkinson Disease, Antiparkinson Agents and Disease Models, Animal. David Standaert has published most often in Mov Disord. David Standaert's most frequent co-authors are Amy W. Amara, MD, PhD, Marissa Dean, MD and Talene A. Yacoubian.

Dmand AI links David Standaert to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Huntington Disease, Parkinson Disease and Chorea.

CMS Open Payments shows 120 general payments to David Standaert from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. Abbvie Inc. paid the most, $41,587. It also lists 15 research payments totaling $2,625 from 2018 to 2020.

David Standaert graduated from Washington University School of Medicine in 1988.